JF
ISPC icon

Jump Financial’s iSpecimen ISPC Stock Holding History

Jump Financial’s Portfolio ISPC Stock Details ISPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-262
Closed -$2.72K – 2137
2025
Q4 		$2.72K Buy
+262
New +$6.64K ﹤0.01% 1892

Other funds holding ISPC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Jump Financial's ISPC Position: Q1 2026 in Review

Jump Financial sold out of iSpecimen (ISPC) in Q1 2026, closing a stake of 262 shares — an estimated $2.72K sold.

Jump Financial first reported a position in ISPC in Q4 2025 and held it in 1 quarter. The position peaked at $2.72K in Q4 2025. 9 funds tracked by Wall St. Rank hold ISPC as of Q1 2026.

  • Jump Financial reported no remaining iSpecimen position as of Q1 2026 after selling out during the quarter.
  • Jump Financial sold 262 iSpecimen shares in Q1 2026, an estimated $2.72K.
  • Jump Financial first reported a position in iSpecimen in Q4 2025 and held it in 1 quarter.
  • Jump Financial's iSpecimen position peaked at $2.72K in Q4 2025.
  • 9 funds tracked by Wall St. Rank held iSpecimen as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.